Skip to content

A Study on Perioperative Symptom Management in Patients Undergoing Sequential Surgery Following AI-Assisted translational therapy for liver cancer

A Study on Perioperative Symptom Management in Patients Undergoing Sequential Surgery Following AI-Assisted translational therapy for liver cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120562
Enrollment
Unknown
Registered
2026-03-17
Start date
2026-03-25
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

Experimental group:Symptom Management Model Based on AI and ePROs. Enter patient records into the system and complete baseline assessments. Primary interventions are as follows: 1) Intelligent Data Se

Sponsors

Chinese Academy of Medical Sciences, Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 75 years; 2. Diagnosed with primary hepatocellular carcinoma based on imaging and histopathological examination; 4. Signed informed consent and voluntarily participates; 5. Able to comprehend study content and submit ePRO data via smartphone login system.

Exclusion criteria

Exclusion criteria: 1. Primary malignant tumors in other systems; 2. History of liver transplantation or liver resection; 3. Patients with organ dysfunction such as chronic heart failure or renal failure, or those with severe complications like anemia or hypoalbuminemia prior to surgery.

Design outcomes

Primary

MeasureTime frame
Mean number of adverse symptom threshold events at 2 weeks postoperatively;

Secondary

MeasureTime frame
Patient Health Questionnaire-9;Generalized Anxiety Disorder-7;World Health Organization Quality of Life-brief version;Unplanned readmission rate;

Countries

China

Contacts

Public ContactXuelei Xu

Chinese Academy of Medical Sciences, Peking Union Medical College Hospital

xuxl20120403@126.com+86 186 1267 2363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026